NDAINJECTIONINJECTABLE
Approved
Jan 1946
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Alcohol 5% and Dextrose 5% is an intravenous injectable combination product used as a nutritional and metabolic support agent. It delivers both dextrose for caloric supplementation and alcohol as a carrier/preservative in peripheral or central IV administration. The product functions primarily as a supportive care agent rather than a primary therapeutic intervention.
LOE Approaching
This is a legacy supportive care product nearing loss of exclusivity with minimal commercial growth potential and likely a small, maintenance-focused team structure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Alcohol 5% and Dextrose 5% offers limited career acceleration given zero linked job openings and a legacy product in LOE-approaching status. Roles are primarily defensive, focused on managing existing hospital relationships and maintaining market presence rather than driving innovation or growth.
Brand ManagerField Sales Representative
Worked on ALCOHOL 5% AND DEXTROSE 5% at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.